Submit Deal

Mark Nathan Lampert

CEO and Founder at BVF PARTNERS

Investor

Deal Bio

Total Deals5

Valued Deals5

Total Value£471M

Avg. Deal Size£94M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (5)

Sort

Canada

Biotechnology

Private EquityAcquisitionPrivateCross BorderVenture CapitalMinority

target

Alpha-9 Theranostics

bidder

Quark Venture

£60m

11 dealmakers

United States

Biotechnology

PrivateAcquisitionVenture CapitalDomesticMinorityPrivate Equity

target

Quanta Therapeutics

bidder

Vida Ventures

£40m

11 dealmakers

United States

Pharmaceuticals

DomesticAcquisitionMinorityPrivate EquityPublic

target

VERASTEM

bidder

Bvf Partners

£48m

4 dealmakers

United States

Biotechnology

MinorityDomesticPrivate EquityAcquisitionPublic

target

Cidara Therapeutics

bidder

Ra Capital Management

£193m

8 dealmakers

United States

Biotechnology

AcquisitionCross BorderMinorityPrivateVenture Capital

target

Third Arc Bio

bidder

Vida Ventures

£127m

14 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy